Probing the differential interactions of quinazolinedione PD 0305970 and quinolones with gyrase and topoisomerase IV

Antimicrobial Agents and Chemotherapy

Volumn 53, Issue 9, 2009, Pages 3822-3831

  Pan, Xiao Su ^a   Gould, Katherine A ^a   Fisher, L Mark ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; DNA TOPOISOMERASE; DNA TOPOISOMERASE (ATP HYDROLYSING); DNA TOPOISOMERASE (ATP HYDROLYSING) A; MAGNESIUM ION; PD 0305970; PROTEIN PARC; QUINAZOLINE DERIVATIVE; QUINOLONE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DNA CLEAVAGE; DNA DENATURATION; DRUG ACTIVITY; DRUG STRUCTURE; GENE MUTATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CLEAVAGE; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN MOTIF; STREPTOCOCCUS PNEUMONIAE;

CIPROFLOXACIN; DNA GYRASE; DNA TOPOISOMERASE IV; MOLECULAR STRUCTURE; MUTATION; POLYMERASE CHAIN REACTION; PYRROLIDINES; QUINAZOLINONES; QUINOLONES; SEQUENCE ANALYSIS, DNA; STREPTOCOCCUS PNEUMONIAE;

EID: 70349126269     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00113-09     Document Type: Article

References (58)

1. Alovero, F. L., X.-S. Pan, J. E. Morris, R. H. Manzo, and L. M. Fisher. 2000. Engineering the specificity of antibacterial fluoroquinolones: benzenesulfonamide modifications at C-7 of ciprofloxacin change its primary target in Streptococcus pneumoniae from topoisomerase IV to gyrase. Antimicrob. Agents Chemother. 44:320-325.
2. Bassetti, M., G. Medica, A. Di Biagio, E. Right, R. Rosso, and D. Bassetti. 2004. New antibiotics for treatment of serious infections due to resistant gram-positive cocci. Rev. Med. Microbiol. 15:109-117.
3. Bellon, S., J. D. Parsons, Y. Wei, K. Hayakawa, L. L. Swenson, P. S. Charifson, J. A. Lippke, R. Aldape, and C. H. Gross. 2004. Crystal structures of Escherichia coli topoisomerase IV ParE subunit (24 and 43 kilodaltons): a single residue dictates differences in novobiocin potency against topoisomerase IV and DNA gyrase. Antimicrob. Agents Chemother. 48:1856-1864.
4. Berger, J. M., S. J. Gamblin, S. C. Harrison, and J. C. Wang. 1996. Structure and mechanism of DNA topoisomerase II. Nature 379:225-232.
5. Champoux, J. J. 2001. DNA topoisomerases: structure, function, and mechanism. Annu. Rev. Biochem. 70:369-413.
6. Coleman, K. 2004. Recent advances in the treatment of gram-positive infections. Drug Disc. Today 1:455-460. (Pubitemid 40197591)
7. Corbett, K. D., and J. M. Berger. 2004. Structure, molecular mechanisms and evolutionary relationships in DNA topoisomerases. Annu. Rev. Biophys. Biomol. Struct. 33:95-118.
8. Corbett, K. D., A. J. Schoeffler, N. D. Thomsen, and J. M. Berger. 2005. The structural basis of substrate specificity in DNA topoisomerase IV. J. Mol. Biol. 351:545-561.
9. Corbett, K. D., R. K. Shultzaberger, and J. M. Berger. 2004. The C-terminal domain of DNA gyrase A adopts a DNA-bending -pinwheel fold. Proc. Natl. Acad. Sci. USA 101:7293-7298.
10. Cullen, M. E., A. W. Wyke, R. Kuroda, and L. M. Fisher. 1989. Cloning and characterization of a DNA gyrase A gene from Escherichia coli that confers clinical resistance to 4-quinolones. Antimicrob. Agents Chemother. 33:886-894.
11. Deweese, J. E., A. E. Burgin, and N. Osheroff. 2008. Human topoisomerase IIα uses a two-metal-ion mechanism for DNA cleavage. Nucleic Acid Res. 36:4883-4893.
12. Dong, K. C., and J. M. Berger. 2007. Structural basis for gate-DNA recognition and bending by type IIA topoisomerases. Nature 450:1201-1206.
13. Drlica, K., M. Mailk, R. J. Kerns, and X. Zhao. 2008. Quinolone-mediated bacterial death. Antimicrob. Agents Chemother. 52:385-392.
14. Ellsworth, E. L., T. P. Tran, H. D. H. Showalter, J. P. Sanchez, B. M. Watson, M. A. Stier, J. M. Domagala, S. J. Gracheck, E. T. Joannides, M. A. Shapiro, S. A. Dunham, D. L. Hanna, M. D. Huband, J. W. Gage, J. C. Bronstein, J. Y. Liu, D. Q. Nguyen, and R. Singh. 2006. 3-Aminoquinazolinediones as a new class of antibacterial agents demonstrating excellent antibacterial activity against wild-type and multidrug resistant organisms. J. Med. Chem. 49:6435-6438.
15. Fass, D., C. E. Bogden, and J. M. Berger. 1999. Quaternary changes in topoisomerase II may direct orthogonal movement of two DNA strands. Nature Struct. Biol. 6:322-326.
16. Fisher, L. M., K. Mizuuchi, M. H. O'Dea, H. Ohmori, and M. Gellert. 1981. Site-specific interactions of DNA gyrase with DNA. Proc. Natl. Acad. Sci. USA 78:4165-4169.
17. Fukuda, H., and K. Hiramatsu. 1999. Primary targets of fluoroquinolones in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 43:410-412.
18. Gellert, M., L. M. Fisher, and M. H. O'Dea. 1979. Purification and catalytic properties of a fragment of DNA gyrase B protein. Proc. Natl. Acad. Sci. USA 76:6289-6293.
19. German, N., M. Malik, J. D. Rosen, K. Drlica, and R. J. Kerns. 2008. Use of gyrase resistance mutants to guide synthesis of 8-methoxy-quinazoline-2,4- diones. Antimicrob. Agents Chemother. 52:3915-3921.
20. Gould, K. A., X.-S. Pan, R. J. Kerns, and L. M. Fisher. 2004. Ciprofloxacin dimers target gyrase in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 48:2108-2115.
21. Heaton, V. J., C. E. Goldsmith, J. E. Ambler, and L. M. Fisher. 1999. Activity of gemifloxacin against penicillin- and ciprofloxacin-resistant Streptococcus pneumoniae displaying topoisomerase- and efflux-mediated resistance mechanisms. Antimicrob. Agents Chemother. 43:2998-3000.
22. Hsieh, T.-J., L. Farh, W. M. Huang, and N. L. Chan. 2004. Structure of the topoisomerase IV C-terminal domain: a broken beta propellor implies a role as a geometry facilitator in catalysis. J. Biol. Chem. 279:55587-55593.
23. Huband, M. D., M. A. Cohen, M. Zurack, D. L. Hanna, L. A. Skerlos, M. C. Sulavik, G. W. Gibson, J. W. Gage, E. Ellsworth, M. A. Stier, and S. J. Gracheck. 2007. In vitro and in vivo activities of PD 0305970 and PD 0326448, new bacterial gyrase/topoisomerase inhibitors with potent antibacterial activities versus multidrug-resistant Gram-positive and fastidious organism groups. Antimicrob. Agents Chemother. 51:1191-1201.
24. Laponogov, I., D. A. Veselkov, M. K. Sohi, X. S. Pan, A. Achari, C. Yang, J. D. Ferrera, L. M. Fisher, and M. R. Sanderson. 2007. Breakage-reunion domain of Streptococcus pneumoniae topoisomerase IV: crystal structure of a Gram-positive quinolone target. PLoS ONE 2:e301.
25. Laponogov, I., M. K. Sohi, D. A. Veselkov, X. S. Pan, R. Sawhney, A. W. Thompson, K. E. McAuley, L. M. Fisher, and M. R. Sanderson. 2009. Structural insight into the quinolone-DNA cleavage complex of type IIA topoisomerases. Nat. Struct. Mol. Biol. 16:667-669.
26. Lecomte, S., M. H. Baron, M. T. Chenon, C. Coupry, and N. J. Moreau. 1994. Effect of magnesium complexation by fluoroquinolones on their bacterial properties. Antimicrob. Agents Chemother. 38:2810-2816.
27. Leo, E., K. A. Gould, X. S. Pan, G. Capranico, M. R. Sanderson, M. Palumbo, and L. M. Fisher. 2005. Novel symmetric and asymmetric DNA scission determinants for Streptococcus pneumoniae topoisomerase IV and gyrase are clustered at the DNA breakage site. J. Biol. Chem. 280:14252-14263.
28. Levy, S. B., and B. Marshall. 2004. Antibiotic resistance worldwide: causes, challenges, and responses. Nat. Med. 10(Suppl. 12):S122-S129.
29. Liu, Q., and J. C. Wang. 1999. Similarity in the catalysis of DNA breakage and rejoining by type IA and type IIA DNA topoisomerases. Proc. Natl. Acad. Sci. USA 96:881-886.
30. Mizuuchi, K., L. M. Fisher, M. H. O'Dea, and M. Gellert. 1980. DNA gyrase action involves the introduction of transient double strand breaks into DNA. Proc. Natl. Acad. Sci. USA 77:1847-1851.
31. Morais-Cabral, J. H., A. P. Jackson, C. V. Smith, N. Shikotra, A. Maxwell, and R. C. Liddington. 1997. Crystal structure of the breakage-reunion domain of DNA gyrase. Nature 388:903-906. (Pubitemid 27377066)
32. Morrissey, I., A. Colclough, and J. Northwood. 2007. TARGETed surveillance: susceptibility of Streptococcus pneumoniae isolated from community-acquired respiratory tract infections in 2003 to fluoroquinolones and other agents. Int. J. Antimicrob. Agents 30:345-351.
33. Munoz, R., and A. G. de la Campa. 1996. ParC subunit of DNA topoisomerase IV of Streptococcus pneumoniae is a primary target of quinolones and cooperates with DNA gyrase A subunit in forming resistance phenotype. Antimicrob. Agents Chemother. 40:2252-2257.
34. Noble, C. G., and A. Maxwell. 2002. The role of GyrB in the DNA cleavage-religation reaction of DNA gyrase: a proposed two metal-ion mechanism. J. Mol. Biol. 318:361-371.
35. Norrby, R. S., C. E. Nord, and R. Finch. 2005. Lack of development of new antimicrobial drugs: a serious threat to public health. Lancet Infect. Dis. 5:115-119.
36. Oram, M., and L. M. Fisher. 1991. 4-Quinolone resistance mutations in the DNA gyrase of Escherichia coli clinical isolates identified by using the polymerase chain reaction. Antimicrob. Agents Chemother. 35:387-389.
37. Palu, G., S. Valisena, G. Ciarrochi, B. Gatto, and M. Palumbo. 1992. Quinolone binding to DNA is mediated by magnesium ions. Proc. Natl. Acad. Sci. USA 89:9671-9675.
38. Pan, X.-S., J. Ambler, S. Mehtar, and L. M. Fisher. 1996. Involvement of topoisomerase IV and gyrase as ciprofloxacin targets in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 40:2321-2326.
39. Pan, X.-S., M. Dias, M. Palumbo, and L. M. Fisher. 2008. Clerocidin selectively modifies the gyrase-DNA gate to induce irreversible and reversible DNA damage. Nucleic Acids Res. 36:5516-5529.
40. Pan, X-S., and L. M. Fisher. 1996. Cloning and characterization of the parC and parE genes of Streptococcus pneumoniae encoding DNA topoisomerase IV: role in fluoroquinolone resistance. J. Bacteriol. 178:4060-4069.
41. Pan, X.-S., and L. M. Fisher. 1997. Targeting of DNA gyrase in Streptococcus pneumoniae by sparfloxacin: selective targeting of gyrase or topoisomerase IV by quinolones. Antimicrob. Agents Chemother. 41:471-474.
42. Pan, X.-S., and L. M. Fisher. 1998. DNA gyrase and topoisomerase IV are dual targets of clinafloxacin action in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 42:2810-2816.
43. Pan, X.-S., and L. M. Fisher. 1999. Streptococcus pneumoniae DNA gyrase and topoisomerase IV: overexpression, purification, and differential inhibition by fluoroquinolones. Antimicrob. Agents Chemother. 43:1129-1136.
44. Pan, X.-S., G. Yague, and L. M. Fisher. 2001. Quinolone resistance mutations in Streptococcus pneumoniae GyrA and ParC proteins: mechanistic insights into quinolone action from enzymatic analysis, intracellular levels, and phenotypes of wild-type and mutant proteins. Antimicrob. Agents Chemother. 45:3140-3147.
45. Perichon, B., J. Tankovic, and P. Courvalin. 1997. Characterization of a mutation in the parE gene that confers fluoroquinolone resistance in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 41:1166-1167.
46. Pletz, M. W. R., L. McGee, J. Jorgensen, B. Beall, R. R. Facklam, C. G. Whitney, K. P. Klugman, and the Active Bacterial Core Surveillance Team. 2004. Levofloxacin-resistant invasive Streptococcus pneumoniae in the United States: evidence for clonal spread and the impact of conjugate pneumococcal vaccine. Antimicrob. Agents Chemother. 48:3491-3497.
47. Ruthenburg, A. J., D. M. Graybosch, J. C. Huetsch, and G. L. Verdine. 2005. A superhelical spiral in the Escherichia coli DNA gyrase A C-terminal domain imparts unidirectional supercoiling bias. J. Biol. Chem. 280:26177-26184.
48. Shen, L. L., J. Baranowski, and A. G. Pernet. 1989. Mechanism of inhibition of DNA gyrase by quinolone antibacterials: specificity and cooperativity of drug binding to DNA. Biochemistry 28:3879-3885. (Pubitemid 19125437)
49. Sissi, C., A. Chemello, E. Vazquez, L. A. Mitchenall, A. Maxwell, and M. Palumbo. 2008. DNA gyrase requires DNA for effective two-site coordination of divalent metal ions: further insight into the mechanism of enzyme action. Biochemistry 47:8538-8545.
50. Tran, T. P., E. L. Ellsworth, J. P. Sanchez, B. M. Watson, M. A. Stier, H. D. H. Showalter, J. M. Domagala, A. A. Shapiro, E. T. Joannides, S. J. Gracheck, D. Q. Nguyen, P. Bird, J. Yip, A. Sharadendu, C. Ha, S. Ramezani, X. Wu, and R. Singh. 2007. Structure-activity relationships of 3- aminoquinazolinediones, a new class of bacterial type-2 topoisomerase (DNA gyrase and topo IV) inhibitors. Bioorg. Med. Chem. Lett. 17:1312-1320.
51. Tran, T. P., E. L. Ellsworth, M. A. Stier, J. M. Domagala, H. D. H. Showalter, S. J. Gracheck, M. A. Shapiro, T. E. Joannides, and R. Singh. 2004. Synthesis and structural-activity relationships of 3-hydroxyquinazoline-2,4- dione antibacterial agents. Bioorg. Med. Chem. Lett. 14:4405-4409.
52. Van Bambeke, F., R. R. Reinert, P. C. Appelbaum, P. M. Tulkens, and W. E. Peetermans. 2007. Multidrug-resistant Streptococcus pneumoniae infections: current and future therapeutic options. Drugs 67:2355-2382.
53. Weigel, L. M., G. J. Anderson, R. R. Facklam, and F. C. Tenover. 2001. Genetic analyses of mutations contributing to fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae. Antimicrob. Agents Chemother. 45:3517-3523.
54. West, K. L., E. L. Meczes, R. Thorn, R. M. Turnbull, R. Marshall, and C. A. Austin. 2000. Mutagenesis of E477 or K505 in the B' domain of human topoisomerase IIβ increases the requirement for magnesium ions during strand passage. Biochemistry 39:1223-1233.
55. Wigley, D. B., G. J. Davies, E. J. Dodson, A. Maxwell, and G. Dodson. 1991. Crystal structure of an N-terminal fragment of the DNA gyrase B protein. Nature 351:624-629.
56. Yague, G., J. E. Morris, X.-S. Pan, K. A. Gould, and L. M. Fisher. 2002. Cleavable complex formation by wild-type and quinolone-resistant Streptococcus pneumoniae type II topoisomerases mediated by gemifloxacin and other fluoroquinolones. Antimicrob. Agents Chemother. 46:413-419.
57. Yoshida, H., M. Bogaki, M. Nakamura, and S. Nakamura. 1990. Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coli. Antimicrob. Agents Chemother. 34:1271-1272. (Pubitemid 20177394)
58. Yoshida, H., M. Bogaki, M. Nakamura, L. M. Yamanaka, and S. Nakamura. 1991. Quinolone resistance-determining region in the DNA gyrase gyrB gene of Escherichia coli. Antimicrob. Agents Chemother. 35:1647-1650.